Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 534 posts found.

Adaptyv Bio creates a new paradigm for protein engineering using generative AI, open-source software and synthetic biology

April 13, 2023
Business Services

Lausanne, Switzerland – 13th April 2023; AI tools like ChatGPT are revolutionizing how the world generates text, images and code. …

News
Press release

BioInnovation Institute & Science Prize for Innovation winners announced

April 13, 2023
Business Services

COPENHAGEN, Denmark, April 13, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, …

News
Press release

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 13, 2023
Sales and Marketing

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

News
Press release

ANGLE plc (“the Company”) Pharma Services Contract with Crescendo Biologics

April 13, 2023
Business Services

ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce that it has signed a …

News
Press release

ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) ACCEPTED FOR USE WITHIN NHS SCOTLAND EARLIER IN THE TREATMENT PATHWAY FOR HER2-POSITIVE METASTATIC BREAST CANCER

April 12, 2023
Business Services

Daiichi Sankyo UK Limited and AstraZeneca UK Limited welcome the news that the Scottish Medicines Consortium (SMC) has accepted Enhertu®▼ …

News
Press release

Almirall, the first to assess wellbeing in a dermatology clinical study

April 12, 2023
Business Services

BARCELONA, Spain. April 12, 2023 – Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced the …

News
Press release

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

April 11, 2023
Business Services

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science …

News
Press release

Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD

April 11, 2023
Business Services

LONDON and RALEIGH, N.C., April 11, 2023 – Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage …

News
Press release

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

April 11, 2023
Business Services

Leiden, The Netherlands, April 11, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) announces the first commercial …

News
Press release

Avacta Opens First Two US Clinical Investigator Sites for AVA6000 Phase 1 Clinical Study

April 6, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces the opening …

News
Press release

Innova Care Concepts expand their support to the medical negligence sector with the acquisition of Nurture Group Ltd.

April 5, 2023
Business Services

Press Release, Wednesday 5th April 2023, London… As part of a long-term strategy to increase its home adaptation services across …

News
Press release

Ipsen’s response to NICE’s decision on Cabometyx® (cabozantinib) for previously treated differentiated thyroid cancer unsuitable for or refractory to radioactive iodine

April 5, 2023
Business Services

  SLOUGH, UK, 5th April 2023 – Ipsen is disappointed that the National Institute for Health and Care Excellence (NICE) …

News
Press release

First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study

April 5, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces that the …

News
Press release

BenevolentAI announces top-line Phase IIa results for its topical pan-Trk inhibitor BEN-2293 (1%) in mild-to-moderate atopic dermatitis

April 5, 2023
Business Services

London, UK, 5 April 2023: BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI) announces top-line results from its Phase IIa, …

News
Press release

Phlo acquires Truepill UK in landmark digital pharmacy consolidation

April 4, 2023
Business Services

Glasgow, UK. Phlo Technologies UK digital pharmacy leaders, have today announced their acquisition of the UK arm of US-based healthcare …

News
Press release

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024